BOZKURT, O. And İNANÇ, M. 2018. PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN. 2 nd International Congress on Oncological Sciences .

BOZKURT, O., & İNANÇ, M., (2018). PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN . 2 nd International Congress on Oncological Sciences

BOZKURT, OKTAY, And MEVLÜDE İNANÇ. "PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN," 2 nd International Congress on Oncological Sciences, 2018

BOZKURT, OKTAY And İNANÇ, MEVLÜDE. "PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN." 2 nd International Congress on Oncological Sciences , 2018

BOZKURT, O. And İNANÇ, M. (2018) . "PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN." 2 nd International Congress on Oncological Sciences .

@conferencepaper{conferencepaper, author={OKTAY BOZKURT And author={MEVLÜDE İNANÇ}, title={PREDICTING THE ROLE OF THE PRETREATMENT NEUTROPHIL TO LYMPHOCYTE RATIO IN THE SURVIVAL OF RECURRENT GLIOBLASTOMA MULTIFORME PATIENTS TREATED WITH BEVACIZUMAB AND IRINOTECAN}, congress name={2 nd International Congress on Oncological Sciences}, city={}, country={}, year={2018}}